Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With PolyneuropathyDavid Adams, Mónica Freitas, Jonas Wixner et al.|JAMA Neurology|2025Cited by 34
Targeted disease-specific therapy for patients with hereditary transthyretin amyloidosis and cardiac involvement after orthotopic liver transplantation. Consensus from the Working Group on Myocardial and Pericardial Diseases of the Portuguese Society of Cardiology and National Reference Centers for Familial AmyloidosisSílvia Aguiar Rosa, Olga Azevedo, Nuno Marques et al.|Revista Portuguesa de Cardiologia|2025Cited by 0